These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22804569)

  • 1. In this issue: harnessing immunity against difficult targets, through the CD40-CD40L pathway.
    Kornbluth RS; Bot A
    Int Rev Immunol; 2012 Aug; 31(4):243-5. PubMed ID: 22804569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells.
    Chougnet C
    J Leukoc Biol; 2003 Nov; 74(5):702-9. PubMed ID: 12960257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 activation: lessons for HIV immunotherapy from malignancies?
    Le Dieu R; Gribben J
    J HIV Ther; 2005 Sep; 10(3):51-5. PubMed ID: 16385972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism and function of CD40/CD40L engagement in the immune system.
    Elgueta R; Benson MJ; de Vries VC; Wasiuk A; Guo Y; Noelle RJ
    Immunol Rev; 2009 May; 229(1):152-72. PubMed ID: 19426221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
    Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
    Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
    Rodríguez-Pinto D; Moreno J
    Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.
    Law CL; Grewal IS
    Adv Exp Med Biol; 2009; 647():8-36. PubMed ID: 19760064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
    Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
    Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 and its ligand in the regulation of humoral immunity.
    Klaus SJ; Berberich I; Shu G; Clark EA
    Semin Immunol; 1994 Oct; 6(5):279-86. PubMed ID: 7532458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
    Wan Y; Ma X; Li X; Yi J
    Med Hypotheses; 2009 Nov; 73(5):835-7. PubMed ID: 19632790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis.
    Munroe ME
    Semin Immunol; 2009 Oct; 21(5):283-8. PubMed ID: 19539498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
    Engel D; Seijkens T; Poggi M; Sanati M; Thevissen L; Beckers L; Wijnands E; Lievens D; Lutgens E
    Semin Immunol; 2009 Oct; 21(5):308-12. PubMed ID: 19616449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.
    Burington B; Yue P; Shi X; Advani R; Lau JT; Tan J; Stinson S; Stinson J; Januario T; de Vos S; Ansell S; Forero-Torres A; Fedorowicz G; Yang TT; Elkins K; Du C; Mohan S; Yu N; Modrusan Z; Seshagiri S; Yu SF; Pandita A; Koeppen H; French D; Polson AG; Offringa R; Whiting N; Ebens A; Dornan D
    Sci Transl Med; 2011 Mar; 3(74):74ra22. PubMed ID: 21411738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CD40 and CD154/CD40L in dendritic cells.
    Ma DY; Clark EA
    Semin Immunol; 2009 Oct; 21(5):265-72. PubMed ID: 19524453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of agonistic monoclonal antibodies against chicken CD40.
    Chen CH; Abi-Ghanem D; Njongmeta L; Bray J; Mwangi W; Waghela SD; McReynolds JL; Ing NH; Berghman LR
    Dev Comp Immunol; 2010 Nov; 34(11):1139-43. PubMed ID: 20599554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity.
    Tang A; Judge TA; Turka LA
    Eur J Immunol; 1997 Dec; 27(12):3143-50. PubMed ID: 9464799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.